buchheit-30-15ift-10_yrs_review_(2000-2010)[1]
TRANSCRIPT
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
1/9
1
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
3015 F :
10
BP U, S S Da, ASPIRE, Aa S E. P.O. B 22287, Da, Qaa.
T.: (+974) 4413 6103. Fa: (+974) 4413 6060. Ea: b@ab. / Wb: ://.ab.
C...1
F ..2
A ...2
A ..3
3015 F
P 3
Rab ..3
Va .3A 3015F ...5
..10
, 3015 (3015 )! 2010, 10 .
! 10 , ()
, / 3015
/
. , , .
. .
.1. . E a 1999. A
a & (S&C) a a a a F
Haba a Sab ( a 4 F ),
I a a LB a
(a a U Ma a T (29))
aa aaa a. W
a (VLB) a a
aa (3, 24). F a, a a
. Ea a a a a ba
aa, I a 8590% VLB 1012
15 . N, a b a
aa a, a a
(.., a
ab VLB), a b . S a
, a a a !? Ta
, I a a aba a a aa (.., 120% VLB)! I a,
a, a a a a a a
: a, , ,
, a ba, . I
a a a a
a (COD)
a a a a a aa
LB a (.., COD ab,
ab, aab aa). I a
a , a, a
aa aa , aa a.
T a a a COD,
a aa a a
, a .
.2 () . I a a a
a, a a a a aa 3015 IFT (7).
O a, a , I a a
a a 30 , ba
, a a, , ! F
a a a a , I a
a: a 40 30 ,
15 a (a) , a a
0.5 / a. T 3015IFT a b J
2000. J a a aa
☺. N a a a a a
a a a Sab (.., aba
a , baba, aba a ba [] b)
b a Y W F Naa
aba Ta 8586 J 2002, a SC Sa Haba
(1
a) A 2003. T aa a
a, a a b & (JSCR) (7)
Db 2004. T a
a a a a 2007, a b Db
2008! (a ba a). I a ,
a , aa a b ba
F aba a a,
2005 (11, 12, 14).
.3. . Ta, aba a Fa a
(a a, , a a a).
N, a a a 2003, a aa a a
a a a a ,
baba (Sab P A, Fa
INSEP, M F Naa Ta 2006), ba (L,
Naa C Caa a a b a
), b (T 14), ba (INSEP), (INSEP,
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
2/9
2
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
a Laa), (F a Sab),
a I , a a a a
a a a ba (UK, Ia, Ga,
B, Qaa, Caaa, USA, Aaa), baba (USA,
Taa), aba (Ga, B, G, Ta, Qaa,
Caa, Raa, Pa), b (Aaa, UK, Ia), AFL
(Aaa), ba (Aaa, N Za), F H
(Ea Naa a, a ). T ab
/a a I a b a , a I a
a b a . I aa,
a a b a
(13) ba a, a
a aa a a
(34) a a a a. Fa,
a a S&C Fa a
a , a a b a,
a a a 30
15IFT ☺.
. F
.1. F ( ), 2. F a (
) a L ( (30) (29))
a aa (.., VaEa (23)), a
a a a ( b) a
aa ab (MAV). W a
aab, a
. A a F 1, a a ,
aa a (VO2a) a BEFORE
. T MAV, VO2a b ,
aa , b
a VO2a (4). I a (F 1),
a a LB a (VLB) = 18 /,
b VO2a = 16.5 / ! A aa VO2a
(16.5 /), a a aab a a. T, VO2a a a
a aa ab ,
a b a a ,
a VO2a. W b a a,
b a VO2a a,
a a
( aab ; a
a I a b a a
a a a 3 /). S VO2a a b
a aa ( ab a
a a a ab ),
a a b a
a a. S a 11.5
/ a aa VO2a;
a b (.., )
a a a a .
.2. A
. I a, a a a,
(a VO2a) ba a a
() a a . A F 1,
a COD, a
VO2/ a .
T, a VO2a (.., ), b VO2a
a a a a baa a
(1). I a , a a
a a a ba
a a. T, a a, a a
b a a V+a , a a
+a VO2a VO2a.
F 1. T VO2 a a (b)
a () . T b a
ba COD, a a
VO2a (VO2a) a a a baa
a a . I a , a a
a a a a a a a a a VO2a, a
.
.3. . A a
aa ab (23). T ,
b a a
a , a LB Va
Ea . I, VO2a a 20
a a a a a
(F 1), a COD ab, a
MAV a. M,
aa
(5). Sa, a/a
a/ a
3015IFT YY (2) baa
a. Aa, MAV a , a
V+a a b . I
a a aa a a
a a
. A a ,
a a.
. A .
T a a , a
b ab a aab (
ab VO2a) a . VO2a a
3070% a b aa aa (.., >1012 /) (3, 18, 25, 35). I
a, ba aaa , a
aa ba a a a
aa a a COD, a
a a a (36).
Fa, a a b a
ab; a a a
aaa/ab/a a
b
a (
(26)).
. A (A) (22). W
b a a, AVR a a a
aa a a a a . T
AVR a a
a a VO2a (.., b
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
3/9
3
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
aa a VO2a, F 2). A
a AVR a b b
aa (22), a baa
b aab aa (a a ),
a a a AVR a
b a. Sa, a a,
a A, a VO2a 18 / a a aa
29 / (a a b a 40
50 ), a a AVR 2918 = 11 /; a a B a a VO2a b a aa 33 /
a a a
(AVR = 14 /). F a 1515 a
120% VO2a (21.5 /) a (25), a a
aa a ( a a b a a a
COD a ab), a
a A a a a a a AVR
(33% . 24% !). Ta a b a
b a. A a a ,
a a 3015IFT a , a
a a, a a AVR. I a a
a ,
a VO2a a a , aa a a a a ab a
aab a.
F 2. Sa a Aab V R (AVR)
a a a a VO2a b aa
. D a aa , a B a a
a AVR a a a AVR, a
a a a a A.
. 3015F : , .
.1. . T 3015IFT 30
15 a . V
a 8 .1
30 , a a b 0.5
/ 30 a a (a a a a
a 10 12 / a ). Pa a
ba a b 40 aa
(F 3) a a a, b a b.
T b a a a
a 3 a a a
a . D 15 ,
a a a a a (a
aa,
a );
a a . Pa a
a a a a b, a
a a aa
a ab a a 3
a a . T aa
a a, a a VIFT.VO2a a b a VIFT a
a: VO2a3015IFT (.1
.1
) = 28.3 2.15 G
0.741 A 0.0357 W + 0.0586 A VIFT + 1.03 VIFT, G a
(a = 2 ; a = 1) , A a, a W .
F 3. Aa a 3015IFT a a
. F a 8.5 .1
(ab 69.2 30 ), b a a
A, C B a . A B
aa, a 8.5 a a A 15
b a a. F a 11.5 .1
(ab
91.2 30 ), b a a A, a
a a 9.5 a B, a B
15 a. N a aa
a a a a
a.
.2.
A ab a a
a aa a b a a a
a a. F a
20 aaa aba a, aa
a a b 0.3 / (95% CL, 0.26
0.46) (8), a a a ab 1 a (.., 0.5/) aa . I, aa a
a b a a 1 a, a a a
a a 0.5 / VIFT a b a baa.
.3. 3015F.
C . S b 3015IFT
a
aa COD, a
a a:
Ra VIFT VO2a ( a a
, VIFT ab a a
a VO2a). T a a aa VO2
a a 3015IFT a a a (.., LB a (15)).
VIFT a a VO2a a aabb a 3015 IFT
a a a (b a
a AVR). T a VIFT a 2
5 / a a VO2a, a b aa
b 40% a a 3015IFT a a L
B a (15).
VIFT a a aa ab ,aab aa ( a a AVR ),
a a COD a, ab
a a ab; a a b
. T
a 60 118 aba a (F 4) (6,7).
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
4/9
4
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
VIFT (km.h-1)
14 15 16 17 18 19 20 21 22
1 0 m
( s )
1.6
1.7
1.8
1.9
2.0
2.1
2.2
2.3
2.4
VIFT (km.h-1)
14 15 16 17 18 19 20 21 22
H R R E
4
5
6
7
8
9
10
11
12n = 60
r = 0.47
P < 0.01
VIFT (km.h-1)
14 15 16 17 18 19 20 21 22
V O 2 m a x ( m l . m i n - 1 . . k g - 1 )
30
35
40
45
50
55
60n = 60
r = 0.68
P < 0.05
n = 60
r = 0.63
P < 0.05
VIFT (km.h-1)
14 15 16 17 18 19 20 21 22
C M J ( c m )
25
30
35
40
45
50
55
60
n = 60
r = 0.65
P < 0.05
.
VIFT
(km.h-1
)
10 12 14 16 18 20 22 24
R S A T o t
( s )
30
35
40
45
50
55 n = 118r = 0.88P < 0.001
F 4. Ra b VIFT a VO2a, a
a (10 a [CMJ]), a
a (HRRE) (7) a a a a
(RSAT a (6 [215
]) (6). T a a V IFT a aa
a.
T a b VIFT a a
, .., a 3015 IFT
a a aa
aa ( a aab aa,
a COD ab). W VLB a
a VO2a ( = 0.96 (29)) a VL20,
b VO2a a COD ab, VIFT a a a b a a ( ab). T,
VIFT a a a a a
a a, b a
VLB VL20. W a a a
b VIFT a VL20 a b
VIFT . VLB VIFT a VL20 a a
(.., VO2a + COD . VO2a VL20 a VLB,
), a b a
( = 0.80 . 0.79, F 5) (7, 14). T a
a a a
COD ab (VL20), b a a
(a VLB a) (32). N,
a 3015 IFT: a
COD, b a a
a a .
VIFT
(km.h-1
)
12 14 16 18 20 22 24
V L - B
( k m
. h - 1 )
10
12
14
16
18
20
22r = 0.79p < 0.001
VIFT
(km.h-1
)
10 12 14 16 18 20 22 24
V L é g e r - 2 0 m
( k m . h
- 1 )
9
10
11
12
13
14
15
16
Garçons
Filles
r = 0.80p < 0.001
F 5. Ra b VIFT VLB VL20. T a
a b V IFT a aa
a (14).
VIFT a a aa a, ..,
a a a , b a
a. T a a , a
, a a a a
a ; aa a
(.., a ) (F 11 a
).
C . F ,
, ,
? T
b aab aa a a
a VIFT a a b
a a a AVR a
a 3015IFT (a a a a a
>VO2a, F 6, AB). A a F 1
a aa a a
a a VO2a, a COD
ab a a a
a VO2a, a a VIFT (F 6,
C). Sa, ab a
VO2/ a a/ a a .
W a ab , a
, a a,
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
5/9
5
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
a, , a a
ab a (.., VO2a a AVR).
F 6. Ia a Aab V
R (AVR), COD a ab aa
VIFT. Pa A: VO2a a, aa
a aab .
T, a VO2a, a AVR ( a a a ), a b a
VO2a a (a a V IFT). Pa B : a
a a a AVR ab a, a a VO2a,
a 3015IFT (1 /). S AVR (
) a a a b
, V IFT, a VO2a, ab
a a a (aab a a) a
a a. Pa C a a COD ab a/
ab V IFT a, b
. A a
F 1, a a
VO2a (a a AVR), a a a a COD a a
a a a VO2a a
, a VIFT. Sa, ab
b aa a VO2/ a a/ aa a, a a . A
AVR, VITF a a COD a ab a
ab a aa a a a
a a.
. T a aa
a a, a
a a a a ,
VIFT a a a aa
a aa a a
. T , a HR
(.., a 120% VO2a), a
ba V IFT, VLB. G
ab , a aa: 95% VIFT 110% VLB (F 7). A
, a aab HR a
baa VIFT a a (3
. 9% a aa). T aa
a
(7).
15-15 at 110% VL-B
Time (min)
00.00 00.05 00.10 00.15
% H R
r e s
50
60
70
80
90
100
15-15 at 95% VIFT
Time (min) 00:00:00 00:05:00 00:10:00 00:15:00
% H R
r e s
50
60
70
80
90
100
F 7. Ha a (HR, a a a HR
) a a aba a
(1515),
VLB ( a) VITF ( a) a
. I a aa a HR a
VIFT a .
. A 3015F .
A , a
a (a ), VIFT a b :
. 1. A
CD (7). S aa VIFT
a a aa ab , aabaa ( a a AVR ), a
a COD a a ab (6, 7),
a aa a aa a a a
a a COD. VIFT
a , a a a
a aab
. 3015F ,
,
. I , a
ba a a a (.., VL
B) baa a
a (.., 20 a 8085% VLB).
F
. A a, VIFT 25 / a a
a a a
(11, 15); a a
a VIFT a (..,
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
6/9
6
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
, F 7). W
a a ab VO2a (.., 110120%
a 1515 a ), VIFT
(.., 100% a a
). T, a
ba b a a
a , a (..,
COD, a) a a,
a a b a a 85 100% VIFT (Tab 1). F a, a a ( F
b F a) a aaab a
://.ab. (9, 11, 12, 31) a a
a aa
ba V IFT.
. 2.
. Aa, VIFT a aa
ab , aab aa ( a a
AVR ), a a COD a a
ab (6, 7). Ta a a a
b a a a .
a. T aaa a, 3015IFT, b a a a a, a b
a ba (a a a ).
b. T aaa a a a
. I , a aba a, V IFT
a a b a aa
a a a a, a
aa a (F 8) (10).
I aba a, VIFT
6 10 5 (16) 9 (21) %
a (
aa a ba VIFT b!),
6% a aba a (.., a a (16)),
a 5% a (21) a (20) a .
H, a a a, a a a a
b b a V IFT (.., aba
a , , a b a).
R C T
V I F T
( k m . h
- 1 )
17
18
19
20
21
22
**
F 8. Ca VIFT a a a a
aba a (F a) (R : a aa a
[ J], C : a a [Sb] T : a
Ca ba [Jaa]) (10). *: a . R (
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
7/9
7
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
4) aba a (16). W
a a b ab a a
a ab , a
a a, .., a b ab a
a.
.4 E B
. W (b
aa ), b a Baba a I
H. F Baba, a
28 , a a b Baba a
( (28)). T a
a 3015IFT
a a a a a 40 . T
a ,
VIFT a (28). I a , a
3015 I I T (3015 IIT) I
H. W a 40 ,
a ab
a (F 10). T a a b
b a, ab a a
a (19).
F 10. Aa a 3015 I I T (3015IIT).
.
.
(%F)
(% F)
B
3' 8588% Sa 5 6 3'
45" 90% 15" a Sa 7'8' 2 3 3'
30" 90% 15" a Sa 7'8' 2 3 3'
30" 90% 30" 40% Sa >12 2 3'
30" 93% 30" a S 40 1012' 2 3 3'
15" 100% 15" a Sa 10' 2 3 3'
15" 95% 15" 25% S 40 15' 2 3'
20" 95% 20" a Sa 7'8' 2 67' a
20" 90% 20" 45% S 30 7'8' 2 67' a
20" 95% 15" a S 30 7'8' 2 67' a
15" 100% 15" a S 40 7'8' 2 67' a
15" 95% 15" 25% Sa 7' 2 67' a
15" 95% 10" a S 40 7' 2 67' a
10" 90% 10" a S 10 6' 2 67' a
10" 95% 10" a Sa 6' 2 67' a
3" 17" a20
6' 2 67' a
2 10 S
1. Ea VIFT a a a a.
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
8/9
8
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
F 11. VIFT a a a (a a a) a a a .
10
12
14
16
18
20
22
24
M S
H S
A F U 1 3 ( 2 0 0 9 )
Q a a H B N a a T a (
J )
A F U 1 4 ( 2 0 0 9 )
S H
B ( R 2 0 0 4 )
A F U 1 5 ( 2 0 0 9 )
Q a a H B N a a T a (
S )
S H
B U 1 8 ( R 2 0 0 4 )
L a a H B ( N 2 2 0 0 3 )
E Y C H B S a b ( 2 0 0 2 )
F C F A ( 2 0 0 4 )
S a H B ( L 1 2 0 0 3 )
E Y C H B S a b ( 2 0 0 4 )
L a a H B
( N 2 2 0 0 4 )
E Y C H B A ( 2 0 0 5 )
A F U 1 7 ( 2 0 0 9 )
S H
B ( N 2 2 0 0 4 )
S a H B ( L 1 2 0 0 4 )
S I G B B ( P A 2 0 0 6 )
E Y C F a J S a b
A F U 1 6 ( 2 0 0 9 )
S a H B ( L 1 2 0 0 6 )
A H B ( N 3 2 0 0 8 )
F T a A
B B ( 2 0 0 6 )
S B
B ( N 3 2 0 0 3 )
S C H B ( L 2 2 0 0 8 )
A F U 1 8 ( 2 0 0 9 )
S B
B
( N 3 2 0 0 2 )
F a C B B I N S E P ( 2 0 0 6 )
8 0 0 1 5 0 0
F H E a A ( 2 0 1 0 )
C a F C A F L ( 2 0 0 9 )
F
( / )
10
12
14
16
18
20
22
24
H S
M S
S H
B U 1 8 ( R 2 0 0 4 )
D E C H B S b ( 2 0 0 2 )
E Y C F a J S b
( 2 0 0 4 )
E Y C
H B S a b ( 2 0 0 2 )
E Y C
H B A ( 2 0 0 5 )
E Y C
H B S a b ( 2 0 0 4 )
D F T a H
B ( 2 0 0 4 )
E L F E S S a b H B ( N 1 2 0 0 3 )
E A L A b b H B ( N 1 2 0 0 5 )
D F T a H
B ( 2 0 0 5 )
A S P T T S a b H B ( N 1 2 0 0 2 )
F T a H
B U 1 7 ( 8 5 8 6 )
F T a H
B U 1 7 ( 9 0 9 1 )
E A L A b b H B ( D 2 2 0 0 8 )
F H E a A ( 2 0 1 0 )
F
( / )
F
-
8/20/2019 Buchheit-30-15IFT-10_yrs_review_(2000-2010)[1]
9/9
9
Myorobie Journal ◦ Vol 1 ◦ Septembre 2010 ◦ http://www.martin-buchheit.net
1. A , C , C. T
a aaaa aa a
aa a .
65: 475479, 1992.
2. B , F, . T YY
: a aa a a
. 38: 3751, 2008.3. B . Ia a a: a a
a a. Sa a a
a . Pa II: aab a a. 31: 75
90., 2001.
4. B , . Sa a
VO2a a a a . 22: 90108.,
1996.
5. B , , C, . La a
': a ' ba baa.
1121, 1999.
6. B . 3015 I F T a a
ab. & 23: 2628, 2008.
7. B . T 3015 I F T: aa
a a a a.
22: 365374, 2008.8. B . T 3015 : ab
a a a a a. I: 10
. Ba, Sba: 2005.
9. B . [Aa
Haba]. 100: 1120, 2008.
10. B . F a a
a a a. & 23: 2931, 2008.
11. B . Ia a aa aa
a a a a 3015 I
F T 1 a. 88: 3646, 2005.
12. B . Ia a aa aa
a a a a 3015 I
F T 2 a. 89: 4147, 2005.
13. B . L 3015 I F T : aa
a b a. 1318, 2006.
14. B . L 3015 I F T : a
a a a a
a ' aa .
87: 2734, 2005.
15. B , A , , , ,
A . Caa a aa a
3015 I . 23: 93100, 2009.
16. B , B, , D, C,
A . Gaba a aba a.
30: 251258, 2009.
17. B , B, , F, A .
P I R Pa: Ca V
Ea I. 29: 307315, 2007.
18. B , , B A, , C
, A . Caa a
aba a. 12: 399405,
2009.
19. B , B, , A .
Rab, , a a 3015
a. I P, 2010.
20. B , A, , ,
A . I aa a a ab
a a aba a: . a a.
5: 152164, 2010.
21. B , , A, , B,
A . Saaa a a aaa
aa a. 40: 362371, 2008.
22. B , , . H a: a aa a a .
95: 19551962, 2003.
23. C . T a : a ab a
://.a./.?=_&=a
&=164%3Aaaab
a&a=33&I=100023&a=.
24. D , A , B . T a,
a a a. 18:
584589., 2004.
25. D , B , , B . Ca
a a a VO2
a aaa . 27: 103115., 2002.
26. . M : a ,
a a a ab .
35: 757777., 2005.
27. B, A A , B . A
a a ab 3015
I F T. S ba, 2010.
28. B, B . L 3015 I F T
aa Baba. 25, 2009.
29. A, B . A
a : U Ma a .
5: 7784., 1980.
30. A, . A aa a 20
VO2 a. 49: 112.,
1982.
31. . H a a
a aa. 17:
4951, 2009.
32. , A, .
Na aa a a a 5 a. 31: 124130, 1999.
33. F, . Maaa aa
a a . 67: 453465,
1989.
34. , , D E, B , CA, B ,
E, B , D . H
a a : a a.
44: 272280, 2004.
35. D, B , B , .
I (a . a) a aa
a a a a
a a. 99: 133142, 2007.
36. , , . Ca
a a a a a a
a aa VO2a. 21: 96101, 2000.